DOI:
10.1055/s-00035026
Applied Clinical Informatics
LinksClose Window
References
Pichereau S, Le Louarn A, Lecomte T, Blasco H, Le Guellec C, Bourgoin H.
Cost-effectiveness of UGT1A1*28 genotyping in preventing severe neutropenia following FOLFIRI therapy in colorectal cancer.
J Pharm Pharm Sci 2010;
13 (04) 615-625.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.